 | • レポートコード：MRC2-11QY02543 • 出版社/出版日：QYResearch / 2020年11月20日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は抗うつ剤のグローバル市場について調査・分析したレポートです。種類別（三環系抗うつ薬、選択的セロトニン再取り込み阻害薬、セロトニン-ノルエピネフリン再取り込み阻害薬、モノアミン酸化酵素阻害薬、セロトニン拮抗薬、再取り込み阻害薬、その他）市場規模、用途別（大うつ病性障害、強迫性障害、全般性不安障害、パニック障害、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別抗うつ剤の競争状況、市場シェア ・世界の抗うつ剤市場：種類別市場規模 2015年-2020年（三環系抗うつ薬、選択的セロトニン再取り込み阻害薬、セロトニン-ノルエピネフリン再取り込み阻害薬、モノアミン酸化酵素阻害薬、セロトニン拮抗薬、再取り込み阻害薬、その他） ・世界の抗うつ剤市場：種類別市場規模予測 2021年-2026年（三環系抗うつ薬、選択的セロトニン再取り込み阻害薬、セロトニン-ノルエピネフリン再取り込み阻害薬、モノアミン酸化酵素阻害薬、セロトニン拮抗薬、再取り込み阻害薬、その他） ・世界の抗うつ剤市場：用途別市場規模 2015年-2020年（大うつ病性障害、強迫性障害、全般性不安障害、パニック障害、その他） ・世界の抗うつ剤市場：用途別市場規模予測 2021年-2026年（大うつ病性障害、強迫性障害、全般性不安障害、パニック障害、その他） ・北米の抗うつ剤市場分析：米国、カナダ ・ヨーロッパの抗うつ剤市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの抗うつ剤市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の抗うつ剤市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの抗うつ剤市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Alkermes、Allergan、Bristol-Myers Squibb、Eli Lilly and Company、GlaxoSmithKline、Lundbeck、Merck、Pfizer、TEVA PHARMACEUTICAL INDUSTRIES、TAKEDA PHARMACEUTICAL ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Antidepressants are drugs used for the treatment of major depressive disorder and other conditions, including dysthymia, anxiety disorders, obsessive–compulsive disorder, eating disorders, chronic pain, neuropathic pain and, in some cases, dysmenorrhoea, snoring, migraine, attention-deficit hyperactivity disorder (ADHD), addiction, dependence, and sleep disorders. They may be prescribed alone or in combination with other medications.
Market Analysis and Insights: Global Anti-Depressant Market
The global Anti-Depressant market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Anti-Depressant Scope and Market Size
Anti-Depressant market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Depressant market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Anti-Depressant market is segmented into
Tricyclic Antidepressants
Selective Serotonin Reuptake Inhibitors
Serotonin-Norepinephrine Reuptake Inhibitors
Monoamine Oxidase Inhibitors
Serotonin Antagonist
Reuptake Inhibitors
Others
Segment by Application, the Anti-Depressant market is segmented into
Major Depressive Disorder
Obsessive-Compulsive Disorder
Generalized Anxiety Disorder
Panic Disorder
Others
Regional and Country-level Analysis
The Anti-Depressant market is analysed and market size information is provided by regions (countries).
The key regions covered in the Anti-Depressant market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Anti-Depressant Market Share Analysis
Anti-Depressant market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Anti-Depressant business, the date to enter into the Anti-Depressant market, Anti-Depressant product introduction, recent developments, etc.
The major vendors covered:
Alkermes
Allergan
Bristol-Myers Squibb
Eli Lilly and Company
GlaxoSmithKline
Lundbeck
Merck
Pfizer
TEVA PHARMACEUTICAL INDUSTRIES
TAKEDA PHARMACEUTICAL
1 Study Coverage
1.1 Anti-Depressant Product Introduction
1.2 Market Segments
1.3 Key Anti-Depressant Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Anti-Depressant Market Size Growth Rate by Type
1.4.2 Tricyclic Antidepressants
1.4.3 Selective Serotonin Reuptake Inhibitors
1.4.4 Serotonin-Norepinephrine Reuptake Inhibitors
1.4.5 Monoamine Oxidase Inhibitors
1.4.6 Serotonin Antagonist
1.4.7 Reuptake Inhibitors
1.4.8 Others
1.5 Market by Application
1.5.1 Global Anti-Depressant Market Size Growth Rate by Application
1.5.2 Major Depressive Disorder
1.5.3 Obsessive-Compulsive Disorder
1.5.4 Generalized Anxiety Disorder
1.5.5 Panic Disorder
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Anti-Depressant Market Size, Estimates and Forecasts
2.1.1 Global Anti-Depressant Revenue 2015-2026
2.1.2 Global Anti-Depressant Sales 2015-2026
2.2 Global Anti-Depressant, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Anti-Depressant Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Anti-Depressant Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Anti-Depressant Competitor Landscape by Players
3.1 Anti-Depressant Sales by Manufacturers
3.1.1 Anti-Depressant Sales by Manufacturers (2015-2020)
3.1.2 Anti-Depressant Sales Market Share by Manufacturers (2015-2020)
3.2 Anti-Depressant Revenue by Manufacturers
3.2.1 Anti-Depressant Revenue by Manufacturers (2015-2020)
3.2.2 Anti-Depressant Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Anti-Depressant Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Anti-Depressant Revenue in 2019
3.2.5 Global Anti-Depressant Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Anti-Depressant Price by Manufacturers
3.4 Anti-Depressant Manufacturing Base Distribution, Product Types
3.4.1 Anti-Depressant Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anti-Depressant Product Type
3.4.3 Date of International Manufacturers Enter into Anti-Depressant Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Anti-Depressant Market Size by Type (2015-2020)
4.1.1 Global Anti-Depressant Sales by Type (2015-2020)
4.1.2 Global Anti-Depressant Revenue by Type (2015-2020)
4.1.3 Anti-Depressant Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Anti-Depressant Market Size Forecast by Type (2021-2026)
4.2.1 Global Anti-Depressant Sales Forecast by Type (2021-2026)
4.2.2 Global Anti-Depressant Revenue Forecast by Type (2021-2026)
4.2.3 Anti-Depressant Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Anti-Depressant Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Anti-Depressant Market Size by Application (2015-2020)
5.1.1 Global Anti-Depressant Sales by Application (2015-2020)
5.1.2 Global Anti-Depressant Revenue by Application (2015-2020)
5.1.3 Anti-Depressant Price by Application (2015-2020)
5.2 Anti-Depressant Market Size Forecast by Application (2021-2026)
5.2.1 Global Anti-Depressant Sales Forecast by Application (2021-2026)
5.2.2 Global Anti-Depressant Revenue Forecast by Application (2021-2026)
5.2.3 Global Anti-Depressant Price Forecast by Application (2021-2026)
6 North America
6.1 North America Anti-Depressant by Country
6.1.1 North America Anti-Depressant Sales by Country
6.1.2 North America Anti-Depressant Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Anti-Depressant Market Facts & Figures by Type
6.3 North America Anti-Depressant Market Facts & Figures by Application
7 Europe
7.1 Europe Anti-Depressant by Country
7.1.1 Europe Anti-Depressant Sales by Country
7.1.2 Europe Anti-Depressant Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Anti-Depressant Market Facts & Figures by Type
7.3 Europe Anti-Depressant Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Anti-Depressant by Region
8.1.1 Asia Pacific Anti-Depressant Sales by Region
8.1.2 Asia Pacific Anti-Depressant Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Anti-Depressant Market Facts & Figures by Type
8.3 Asia Pacific Anti-Depressant Market Facts & Figures by Application
9 Latin America
9.1 Latin America Anti-Depressant by Country
9.1.1 Latin America Anti-Depressant Sales by Country
9.1.2 Latin America Anti-Depressant Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Anti-Depressant Market Facts & Figures by Type
9.3 Central & South America Anti-Depressant Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Anti-Depressant by Country
10.1.1 Middle East and Africa Anti-Depressant Sales by Country
10.1.2 Middle East and Africa Anti-Depressant Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Anti-Depressant Market Facts & Figures by Type
10.3 Middle East and Africa Anti-Depressant Market Facts & Figures by Application
11 Company Profiles
11.1 Alkermes
11.1.1 Alkermes Corporation Information
11.1.2 Alkermes Description and Business Overview
11.1.3 Alkermes Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Alkermes Anti-Depressant Products Offered
11.1.5 Alkermes Related Developments
11.2 Allergan
11.2.1 Allergan Corporation Information
11.2.2 Allergan Description and Business Overview
11.2.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Allergan Anti-Depressant Products Offered
11.2.5 Allergan Related Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Corporation Information
11.3.2 Bristol-Myers Squibb Description and Business Overview
11.3.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bristol-Myers Squibb Anti-Depressant Products Offered
11.3.5 Bristol-Myers Squibb Related Developments
11.4 Eli Lilly and Company
11.4.1 Eli Lilly and Company Corporation Information
11.4.2 Eli Lilly and Company Description and Business Overview
11.4.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Eli Lilly and Company Anti-Depressant Products Offered
11.4.5 Eli Lilly and Company Related Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Corporation Information
11.5.2 GlaxoSmithKline Description and Business Overview
11.5.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.5.4 GlaxoSmithKline Anti-Depressant Products Offered
11.5.5 GlaxoSmithKline Related Developments
11.6 Lundbeck
11.6.1 Lundbeck Corporation Information
11.6.2 Lundbeck Description and Business Overview
11.6.3 Lundbeck Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Lundbeck Anti-Depressant Products Offered
11.6.5 Lundbeck Related Developments
11.7 Merck
11.7.1 Merck Corporation Information
11.7.2 Merck Description and Business Overview
11.7.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Merck Anti-Depressant Products Offered
11.7.5 Merck Related Developments
11.8 Pfizer
11.8.1 Pfizer Corporation Information
11.8.2 Pfizer Description and Business Overview
11.8.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Pfizer Anti-Depressant Products Offered
11.8.5 Pfizer Related Developments
11.9 TEVA PHARMACEUTICAL INDUSTRIES
11.9.1 TEVA PHARMACEUTICAL INDUSTRIES Corporation Information
11.9.2 TEVA PHARMACEUTICAL INDUSTRIES Description and Business Overview
11.9.3 TEVA PHARMACEUTICAL INDUSTRIES Sales, Revenue and Gross Margin (2015-2020)
11.9.4 TEVA PHARMACEUTICAL INDUSTRIES Anti-Depressant Products Offered
11.9.5 TEVA PHARMACEUTICAL INDUSTRIES Related Developments
11.10 TAKEDA PHARMACEUTICAL
11.10.1 TAKEDA PHARMACEUTICAL Corporation Information
11.10.2 TAKEDA PHARMACEUTICAL Description and Business Overview
11.10.3 TAKEDA PHARMACEUTICAL Sales, Revenue and Gross Margin (2015-2020)
11.10.4 TAKEDA PHARMACEUTICAL Anti-Depressant Products Offered
11.10.5 TAKEDA PHARMACEUTICAL Related Developments
11.1 Alkermes
11.1.1 Alkermes Corporation Information
11.1.2 Alkermes Description and Business Overview
11.1.3 Alkermes Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Alkermes Anti-Depressant Products Offered
11.1.5 Alkermes Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Anti-Depressant Market Estimates and Projections by Region
12.1.1 Global Anti-Depressant Sales Forecast by Regions 2021-2026
12.1.2 Global Anti-Depressant Revenue Forecast by Regions 2021-2026
12.2 North America Anti-Depressant Market Size Forecast (2021-2026)
12.2.1 North America: Anti-Depressant Sales Forecast (2021-2026)
12.2.2 North America: Anti-Depressant Revenue Forecast (2021-2026)
12.2.3 North America: Anti-Depressant Market Size Forecast by Country (2021-2026)
12.3 Europe Anti-Depressant Market Size Forecast (2021-2026)
12.3.1 Europe: Anti-Depressant Sales Forecast (2021-2026)
12.3.2 Europe: Anti-Depressant Revenue Forecast (2021-2026)
12.3.3 Europe: Anti-Depressant Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Anti-Depressant Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Anti-Depressant Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Anti-Depressant Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Anti-Depressant Market Size Forecast by Region (2021-2026)
12.5 Latin America Anti-Depressant Market Size Forecast (2021-2026)
12.5.1 Latin America: Anti-Depressant Sales Forecast (2021-2026)
12.5.2 Latin America: Anti-Depressant Revenue Forecast (2021-2026)
12.5.3 Latin America: Anti-Depressant Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Anti-Depressant Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Anti-Depressant Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Anti-Depressant Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Anti-Depressant Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Anti-Depressant Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Anti-Depressant Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Anti-Depressant Market Segments
Table 2. Ranking of Global Top Anti-Depressant Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Anti-Depressant Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Tricyclic Antidepressants
Table 5. Major Manufacturers of Selective Serotonin Reuptake Inhibitors
Table 6. Major Manufacturers of Serotonin-Norepinephrine Reuptake Inhibitors
Table 7. Major Manufacturers of Monoamine Oxidase Inhibitors
Table 8. Major Manufacturers of Serotonin Antagonist
Table 9. Major Manufacturers of Reuptake Inhibitors
Table 10. Major Manufacturers of Others
Table 11. Global Anti-Depressant Market Size Growth Rate by Application 2020-2026 (K Units)
Table 12. Global Anti-Depressant Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 13. Global Anti-Depressant Sales by Regions 2015-2020 (K Units)
Table 14. Global Anti-Depressant Sales Market Share by Regions (2015-2020)
Table 15. Global Anti-Depressant Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Anti-Depressant Sales by Manufacturers (2015-2020) (K Units)
Table 17. Global Anti-Depressant Sales Share by Manufacturers (2015-2020)
Table 18. Global Anti-Depressant Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Anti-Depressant by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Depressant as of 2019)
Table 20. Anti-Depressant Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Anti-Depressant Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Anti-Depressant Price (2015-2020) (USD/Unit)
Table 23. Anti-Depressant Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Anti-Depressant Product Type
Table 25. Date of International Manufacturers Enter into Anti-Depressant Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Anti-Depressant Sales by Type (2015-2020) (K Units)
Table 28. Global Anti-Depressant Sales Share by Type (2015-2020)
Table 29. Global Anti-Depressant Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Anti-Depressant Revenue Share by Type (2015-2020)
Table 31. Anti-Depressant Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 32. Global Anti-Depressant Sales by Application (2015-2020) (K Units)
Table 33. Global Anti-Depressant Sales Share by Application (2015-2020)
Table 34. North America Anti-Depressant Sales by Country (2015-2020) (K Units)
Table 35. North America Anti-Depressant Sales Market Share by Country (2015-2020)
Table 36. North America Anti-Depressant Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Anti-Depressant Revenue Market Share by Country (2015-2020)
Table 38. North America Anti-Depressant Sales by Type (2015-2020) (K Units)
Table 39. North America Anti-Depressant Sales Market Share by Type (2015-2020)
Table 40. North America Anti-Depressant Sales by Application (2015-2020) (K Units)
Table 41. North America Anti-Depressant Sales Market Share by Application (2015-2020)
Table 42. Europe Anti-Depressant Sales by Country (2015-2020) (K Units)
Table 43. Europe Anti-Depressant Sales Market Share by Country (2015-2020)
Table 44. Europe Anti-Depressant Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Anti-Depressant Revenue Market Share by Country (2015-2020)
Table 46. Europe Anti-Depressant Sales by Type (2015-2020) (K Units)
Table 47. Europe Anti-Depressant Sales Market Share by Type (2015-2020)
Table 48. Europe Anti-Depressant Sales by Application (2015-2020) (K Units)
Table 49. Europe Anti-Depressant Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Anti-Depressant Sales by Region (2015-2020) (K Units)
Table 51. Asia Pacific Anti-Depressant Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Anti-Depressant Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Anti-Depressant Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Anti-Depressant Sales by Type (2015-2020) (K Units)
Table 55. Asia Pacific Anti-Depressant Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Anti-Depressant Sales by Application (2015-2020) (K Units)
Table 57. Asia Pacific Anti-Depressant Sales Market Share by Application (2015-2020)
Table 58. Latin America Anti-Depressant Sales by Country (2015-2020) (K Units)
Table 59. Latin America Anti-Depressant Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Anti-Depressant Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Anti-Depressant Revenue Market Share by Country (2015-2020)
Table 62. Latin America Anti-Depressant Sales by Type (2015-2020) (K Units)
Table 63. Latin America Anti-Depressant Sales Market Share by Type (2015-2020)
Table 64. Latin America Anti-Depressant Sales by Application (2015-2020) (K Units)
Table 65. Latin America Anti-Depressant Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Anti-Depressant Sales by Country (2015-2020) (K Units)
Table 67. Middle East and Africa Anti-Depressant Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Anti-Depressant Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Anti-Depressant Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Anti-Depressant Sales by Type (2015-2020) (K Units)
Table 71. Middle East and Africa Anti-Depressant Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Anti-Depressant Sales by Application (2015-2020) (K Units)
Table 73. Middle East and Africa Anti-Depressant Sales Market Share by Application (2015-2020)
Table 74. Alkermes Corporation Information
Table 75. Alkermes Description and Major Businesses
Table 76. Alkermes Anti-Depressant Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Alkermes Product
Table 78. Alkermes Recent Development
Table 79. Allergan Corporation Information
Table 80. Allergan Description and Major Businesses
Table 81. Allergan Anti-Depressant Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Allergan Product
Table 83. Allergan Recent Development
Table 84. Bristol-Myers Squibb Corporation Information
Table 85. Bristol-Myers Squibb Description and Major Businesses
Table 86. Bristol-Myers Squibb Anti-Depressant Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Bristol-Myers Squibb Product
Table 88. Bristol-Myers Squibb Recent Development
Table 89. Eli Lilly and Company Corporation Information
Table 90. Eli Lilly and Company Description and Major Businesses
Table 91. Eli Lilly and Company Anti-Depressant Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Eli Lilly and Company Product
Table 93. Eli Lilly and Company Recent Development
Table 94. GlaxoSmithKline Corporation Information
Table 95. GlaxoSmithKline Description and Major Businesses
Table 96. GlaxoSmithKline Anti-Depressant Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. GlaxoSmithKline Product
Table 98. GlaxoSmithKline Recent Development
Table 99. Lundbeck Corporation Information
Table 100. Lundbeck Description and Major Businesses
Table 101. Lundbeck Anti-Depressant Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Lundbeck Product
Table 103. Lundbeck Recent Development
Table 104. Merck Corporation Information
Table 105. Merck Description and Major Businesses
Table 106. Merck Anti-Depressant Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Merck Product
Table 108. Merck Recent Development
Table 109. Pfizer Corporation Information
Table 110. Pfizer Description and Major Businesses
Table 111. Pfizer Anti-Depressant Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Pfizer Product
Table 113. Pfizer Recent Development
Table 114. TEVA PHARMACEUTICAL INDUSTRIES Corporation Information
Table 115. TEVA PHARMACEUTICAL INDUSTRIES Description and Major Businesses
Table 116. TEVA PHARMACEUTICAL INDUSTRIES Anti-Depressant Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. TEVA PHARMACEUTICAL INDUSTRIES Product
Table 118. TEVA PHARMACEUTICAL INDUSTRIES Recent Development
Table 119. TAKEDA PHARMACEUTICAL Corporation Information
Table 120. TAKEDA PHARMACEUTICAL Description and Major Businesses
Table 121. TAKEDA PHARMACEUTICAL Anti-Depressant Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. TAKEDA PHARMACEUTICAL Product
Table 123. TAKEDA PHARMACEUTICAL Recent Development
Table 124. Global Anti-Depressant Sales Forecast by Regions (2021-2026) (K Units)
Table 125. Global Anti-Depressant Sales Market Share Forecast by Regions (2021-2026)
Table 126. Global Anti-Depressant Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 127. Global Anti-Depressant Revenue Market Share Forecast by Regions (2021-2026)
Table 128. North America: Anti-Depressant Sales Forecast by Country (2021-2026) (K Units)
Table 129. North America: Anti-Depressant Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Europe: Anti-Depressant Sales Forecast by Country (2021-2026) (K Units)
Table 131. Europe: Anti-Depressant Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Asia Pacific: Anti-Depressant Sales Forecast by Region (2021-2026) (K Units)
Table 133. Asia Pacific: Anti-Depressant Revenue Forecast by Region (2021-2026) (US$ Million)
Table 134. Latin America: Anti-Depressant Sales Forecast by Country (2021-2026) (K Units)
Table 135. Latin America: Anti-Depressant Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Middle East and Africa: Anti-Depressant Sales Forecast by Country (2021-2026) (K Units)
Table 137. Middle East and Africa: Anti-Depressant Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 139. Key Challenges
Table 140. Market Risks
Table 141. Main Points Interviewed from Key Anti-Depressant Players
Table 142. Anti-Depressant Customers List
Table 143. Anti-Depressant Distributors List
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-Depressant Product Picture
Figure 2. Global Anti-Depressant Sales Market Share by Type in 2020 & 2026
Figure 3. Tricyclic Antidepressants Product Picture
Figure 4. Selective Serotonin Reuptake Inhibitors Product Picture
Figure 5. Serotonin-Norepinephrine Reuptake Inhibitors Product Picture
Figure 6. Monoamine Oxidase Inhibitors Product Picture
Figure 7. Serotonin Antagonist Product Picture
Figure 8. Reuptake Inhibitors Product Picture
Figure 9. Others Product Picture
Figure 10. Global Anti-Depressant Sales Market Share by Application in 2020 & 2026
Figure 11. Major Depressive Disorder
Figure 12. Obsessive-Compulsive Disorder
Figure 13. Generalized Anxiety Disorder
Figure 14. Panic Disorder
Figure 15. Others
Figure 16. Anti-Depressant Report Years Considered
Figure 17. Global Anti-Depressant Market Size 2015-2026 (US$ Million)
Figure 18. Global Anti-Depressant Sales 2015-2026 (K Units)
Figure 19. Global Anti-Depressant Market Size Market Share by Region: 2020 Versus 2026
Figure 20. Global Anti-Depressant Sales Market Share by Region (2015-2020)
Figure 21. Global Anti-Depressant Sales Market Share by Region in 2019
Figure 22. Global Anti-Depressant Revenue Market Share by Region (2015-2020)
Figure 23. Global Anti-Depressant Revenue Market Share by Region in 2019
Figure 24. Global Anti-Depressant Sales Share by Manufacturer in 2019
Figure 25. The Top 10 and 5 Players Market Share by Anti-Depressant Revenue in 2019
Figure 26. Anti-Depressant Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Anti-Depressant Sales Market Share by Type (2015-2020)
Figure 28. Global Anti-Depressant Sales Market Share by Type in 2019
Figure 29. Global Anti-Depressant Revenue Market Share by Type (2015-2020)
Figure 30. Global Anti-Depressant Revenue Market Share by Type in 2019
Figure 31. Global Anti-Depressant Market Share by Price Range (2015-2020)
Figure 32. Global Anti-Depressant Sales Market Share by Application (2015-2020)
Figure 33. Global Anti-Depressant Sales Market Share by Application in 2019
Figure 34. Global Anti-Depressant Revenue Market Share by Application (2015-2020)
Figure 35. Global Anti-Depressant Revenue Market Share by Application in 2019
Figure 36. North America Anti-Depressant Sales Growth Rate 2015-2020 (K Units)
Figure 37. North America Anti-Depressant Revenue Growth Rate 2015-2020 (US$ Million)
Figure 38. North America Anti-Depressant Sales Market Share by Country in 2019
Figure 39. North America Anti-Depressant Revenue Market Share by Country in 2019
Figure 40. U.S. Anti-Depressant Sales Growth Rate (2015-2020) (K Units)
Figure 41. U.S. Anti-Depressant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Canada Anti-Depressant Sales Growth Rate (2015-2020) (K Units)
Figure 43. Canada Anti-Depressant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. North America Anti-Depressant Market Share by Type in 2019
Figure 45. North America Anti-Depressant Market Share by Application in 2019
Figure 46. Europe Anti-Depressant Sales Growth Rate 2015-2020 (K Units)
Figure 47. Europe Anti-Depressant Revenue Growth Rate 2015-2020 (US$ Million)
Figure 48. Europe Anti-Depressant Sales Market Share by Country in 2019
Figure 49. Europe Anti-Depressant Revenue Market Share by Country in 2019
Figure 50. Germany Anti-Depressant Sales Growth Rate (2015-2020) (K Units)
Figure 51. Germany Anti-Depressant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. France Anti-Depressant Sales Growth Rate (2015-2020) (K Units)
Figure 53. France Anti-Depressant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. U.K. Anti-Depressant Sales Growth Rate (2015-2020) (K Units)
Figure 55. U.K. Anti-Depressant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Italy Anti-Depressant Sales Growth Rate (2015-2020) (K Units)
Figure 57. Italy Anti-Depressant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Russia Anti-Depressant Sales Growth Rate (2015-2020) (K Units)
Figure 59. Russia Anti-Depressant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Europe Anti-Depressant Market Share by Type in 2019
Figure 61. Europe Anti-Depressant Market Share by Application in 2019
Figure 62. Asia Pacific Anti-Depressant Sales Growth Rate 2015-2020 (K Units)
Figure 63. Asia Pacific Anti-Depressant Revenue Growth Rate 2015-2020 (US$ Million)
Figure 64. Asia Pacific Anti-Depressant Sales Market Share by Region in 2019
Figure 65. Asia Pacific Anti-Depressant Revenue Market Share by Region in 2019
Figure 66. China Anti-Depressant Sales Growth Rate (2015-2020) (K Units)
Figure 67. China Anti-Depressant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Japan Anti-Depressant Sales Growth Rate (2015-2020) (K Units)
Figure 69. Japan Anti-Depressant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. South Korea Anti-Depressant Sales Growth Rate (2015-2020) (K Units)
Figure 71. South Korea Anti-Depressant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. India Anti-Depressant Sales Growth Rate (2015-2020) (K Units)
Figure 73. India Anti-Depressant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Australia Anti-Depressant Sales Growth Rate (2015-2020) (K Units)
Figure 75. Australia Anti-Depressant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Taiwan Anti-Depressant Sales Growth Rate (2015-2020) (K Units)
Figure 77. Taiwan Anti-Depressant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Indonesia Anti-Depressant Sales Growth Rate (2015-2020) (K Units)
Figure 79. Indonesia Anti-Depressant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Thailand Anti-Depressant Sales Growth Rate (2015-2020) (K Units)
Figure 81. Thailand Anti-Depressant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Malaysia Anti-Depressant Sales Growth Rate (2015-2020) (K Units)
Figure 83. Malaysia Anti-Depressant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Philippines Anti-Depressant Sales Growth Rate (2015-2020) (K Units)
Figure 85. Philippines Anti-Depressant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Vietnam Anti-Depressant Sales Growth Rate (2015-2020) (K Units)
Figure 87. Vietnam Anti-Depressant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Asia Pacific Anti-Depressant Market Share by Type in 2019
Figure 89. Asia Pacific Anti-Depressant Market Share by Application in 2019
Figure 90. Latin America Anti-Depressant Sales Growth Rate 2015-2020 (K Units)
Figure 91. Latin America Anti-Depressant Revenue Growth Rate 2015-2020 (US$ Million)
Figure 92. Latin America Anti-Depressant Sales Market Share by Country in 2019
Figure 93. Latin America Anti-Depressant Revenue Market Share by Country in 2019
Figure 94. Mexico Anti-Depressant Sales Growth Rate (2015-2020) (K Units)
Figure 95. Mexico Anti-Depressant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Brazil Anti-Depressant Sales Growth Rate (2015-2020) (K Units)
Figure 97. Brazil Anti-Depressant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Argentina Anti-Depressant Sales Growth Rate (2015-2020) (K Units)
Figure 99. Argentina Anti-Depressant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Latin America Anti-Depressant Market Share by Type in 2019
Figure 101. Latin America Anti-Depressant Market Share by Application in 2019
Figure 102. Middle East and Africa Anti-Depressant Sales Growth Rate 2015-2020 (K Units)
Figure 103. Middle East and Africa Anti-Depressant Revenue Growth Rate 2015-2020 (US$ Million)
Figure 104. Middle East and Africa Anti-Depressant Sales Market Share by Country in 2019
Figure 105. Middle East and Africa Anti-Depressant Revenue Market Share by Country in 2019
Figure 106. Turkey Anti-Depressant Sales Growth Rate (2015-2020) (K Units)
Figure 107. Turkey Anti-Depressant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Saudi Arabia Anti-Depressant Sales Growth Rate (2015-2020) (K Units)
Figure 109. Saudi Arabia Anti-Depressant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. U.A.E Anti-Depressant Sales Growth Rate (2015-2020) (K Units)
Figure 111. U.A.E Anti-Depressant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 112. Middle East and Africa Anti-Depressant Market Share by Type in 2019
Figure 113. Middle East and Africa Anti-Depressant Market Share by Application in 2019
Figure 114. North America Anti-Depressant Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. North America Anti-Depressant Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Europe Anti-Depressant Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Europe Anti-Depressant Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Asia Pacific Anti-Depressant Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Asia Pacific Anti-Depressant Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Latin America Anti-Depressant Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 121. Latin America Anti-Depressant Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Middle East and Africa Anti-Depressant Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 123. Middle East and Africa Anti-Depressant Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Porter's Five Forces Analysis
Figure 125. Channels of Distribution
Figure 126. Distributors Profiles
Figure 127. Bottom-up and Top-down Approaches for This Report
Figure 128. Data Triangulation
Figure 129. Key Executives Interviewed
うつ病性障害の世界市場（～2026年） Depression includes a variety of mental health problems characterized by the absence of a positive emotion, low mood, and a range of associated cognitive, physical, emotional, and behavioral symptoms. It is a very common condition that affects 1 in every 5 Americans. There are many factors including…- 産後うつ病治療薬の世界市場（～2026年） Postpartum depression is a prevalent disorder affecting many women of reproductive age. Mood stabilizing medications reduce the risk of postpartum bipolar depression relapse but no randomized controlled trials have examined their use in the acute or prophylactic treatment of postpartum bipolar depre…
- 産後うつ病治療の世界市場（～2026年） Market Analysis and Insights: Global Postpartum Depression Treatment Market The global Postpartum Depression Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Postpartum Depression Treatment Scope and Market Si…
- 流動点降下剤の世界市場（～2026年） Pour point depressants are used to allow the use of petroleum based mineral oils at lower temperatures. The lowest temperature at which a fuel or oil will pour is called a pour point. Wax crystals, which form at lower temperatures, may interfere with lubrication of mechanical equipment. High-quality…
- 慢性うつ病性人格障害治療の世界市場（～2026年） Chronic depressive personality disorder also known as Dysthymia is a chronic form of depression. It is mild form of depression which last up to two years or more. This disorder is less severe in comparison to other forms of depression. Symptoms of chronic depressive personality disorder are loss of …